These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Medical Management of Meningiomas: Current Status, Failed Treatments, and Promising Horizons. Karsy M; Guan J; Cohen A; Colman H; Jensen RL Neurosurg Clin N Am; 2016 Apr; 27(2):249-60. PubMed ID: 27012389 [TBL] [Abstract][Full Text] [Related]
6. Treatment of high risk or recurrent meningiomas with hydroxyurea. Rosenthal MA; Ashley DL; Cher L J Clin Neurosci; 2002 Mar; 9(2):156-8. PubMed ID: 11922703 [TBL] [Abstract][Full Text] [Related]
7. The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments. Choy W; Kim W; Nagasawa D; Stramotas S; Yew A; Gopen Q; Parsa AT; Yang I Neurosurg Focus; 2011 May; 30(5):E6. PubMed ID: 21529177 [TBL] [Abstract][Full Text] [Related]
8. Chemotherapy: What is its role in meningioma? Sherman WJ; Raizer JJ Expert Rev Neurother; 2012 Oct; 12(10):1189-95; quiz 1196. PubMed ID: 23082735 [TBL] [Abstract][Full Text] [Related]
11. Molecular genetics of meningiomas: from basic research to potential clinical applications. Simon M; Boström JP; Hartmann C Neurosurgery; 2007 May; 60(5):787-98; discussion 787-98. PubMed ID: 17460514 [TBL] [Abstract][Full Text] [Related]
12. Chromosomal alterations, prognostic factors, and targeted molecular therapies for malignant meningiomas. Yew A; Trang A; Nagasawa DT; Spasic M; Choy W; Garcia HM; Yang I J Clin Neurosci; 2013 Jan; 20(1):17-22. PubMed ID: 22743042 [TBL] [Abstract][Full Text] [Related]
13. The role of chemotherapy and targeted therapy in the treatment of intracranial meningioma. Chamberlain MC Curr Opin Oncol; 2012 Nov; 24(6):666-71. PubMed ID: 22759739 [TBL] [Abstract][Full Text] [Related]
14. [Meningiomas: new prognostic factors]. Sanz Esponera J An R Acad Nac Med (Madr); 2007; 124(2):319-32; discussion 330-2. PubMed ID: 18069599 [TBL] [Abstract][Full Text] [Related]
15. [Nonsurgical methods in the treatment of meningiomas]. Kozlov AV Zh Vopr Neirokhir Im N N Burdenko; 2001; (2):29-32; discussion 32. PubMed ID: 11558171 [No Abstract] [Full Text] [Related]
16. Interferon-alpha for recurrent World Health Organization grade 1 intracranial meningiomas. Chamberlain MC; Glantz MJ Cancer; 2008 Oct; 113(8):2146-51. PubMed ID: 18756531 [TBL] [Abstract][Full Text] [Related]
17. Future treatment modalities for meningiomas: targeting of neurofibromatosis type 2 and Ras-regulated pathways. Evans JJ; Lee JH; Park YS; Jeun SS; Harwalkar JA; Safayhi H; Golubic M Neurosurg Clin N Am; 2000 Oct; 11(4):717-33. PubMed ID: 11082181 [No Abstract] [Full Text] [Related]
19. Novel Medical Therapies in Meningiomas. Danish H; Brastianos P Adv Exp Med Biol; 2023; 1416():213-223. PubMed ID: 37432630 [TBL] [Abstract][Full Text] [Related]
20. Contemporary management of meningiomas: radiation therapy as an adjuvant and radiosurgery as an alternative to surgical removal? Lunsford LD J Neurosurg; 1994 Feb; 80(2):187-90. PubMed ID: 8283254 [No Abstract] [Full Text] [Related] [Next] [New Search]